NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
0.7000
+0.0247 (3.66%)
At close: Mar 26, 2026, 4:00 PM EDT
0.7045
+0.0045 (0.64%)
After-hours: Mar 26, 2026, 5:38 PM EDT
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $5.7 million as of March 26, 2026. Its market cap has decreased by -73.76% in one year.
Market Cap
5.70M
Enterprise Value
8.04M
1-Year Change
-73.76%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has decreased from $19.59M to $5.70M, a decrease of -70.90%. That is a compound annual growth rate of -25.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 5.50M | -58.06% |
| Dec 31, 2025 | 13.11M | -60.90% |
| Dec 31, 2024 | 33.53M | 175.32% |
| Dec 29, 2023 | 12.18M | 74.85% |
| Dec 30, 2022 | 6.97M | -52.05% |
| Dec 31, 2021 | 14.52M | -25.85% |
| Dec 22, 2021 | 19.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ekso Bionics Holdings | 37.42M |
| Precision Optics Corporation | 33.04M |
| Nephros | 32.47M |
| Femasys | 30.88M |
| Milestone Scientific | 24.42M |
| Retractable Technologies | 21.55M |
| Jin Medical International | 15.19M |
| Bionano Genomics | 13.02M |